**RFK Jr. remains firmly in place as HHS Secretary with no signs of imminent departure.** Recent developments include elevating senior advisors and counselors in mid-September 2026 to accelerate the Make America Healthy Again agenda ahead of midterms, alongside continued leadership on vaccine policy revisions, agency staffing, and public health initiatives. He is scheduled to keynote an event tied to his former advocacy group, signaling sustained alignment with administration priorities. While facing ongoing criticism over measles outbreaks, immunization schedule changes, and internal agency shifts, no official announcements, Senate actions, or White House signals point to resignation or removal before year-end. Trader pricing at 78% for “No” reflects this continuity, consistent with his more than year-long tenure and active role in department operations.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$24,819 Vol.
$24,819 Vol.
$24,819 Vol.
$24,819 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...**RFK Jr. remains firmly in place as HHS Secretary with no signs of imminent departure.** Recent developments include elevating senior advisors and counselors in mid-September 2026 to accelerate the Make America Healthy Again agenda ahead of midterms, alongside continued leadership on vaccine policy revisions, agency staffing, and public health initiatives. He is scheduled to keynote an event tied to his former advocacy group, signaling sustained alignment with administration priorities. While facing ongoing criticism over measles outbreaks, immunization schedule changes, and internal agency shifts, no official announcements, Senate actions, or White House signals point to resignation or removal before year-end. Trader pricing at 78% for “No” reflects this continuity, consistent with his more than year-long tenure and active role in department operations.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions